Clinical Trial Update: Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating a fixed-duration regimen of pirtobrutinib plus obinutuzumab in chronic lymphocytic leukemia or small lymphocytic lymphoma is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Obinutuzumab (obinutuzumab)
• Pirtobrutinib (pirtobrutinib)

Snippet

Sponsor: Inhye Ahn | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: RECRUITING